A carregar...

Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors

BACKGROUND: Both endometrial cancer and postmenopausal breast cancer risk are increased by obesity and higher endogenous estrogen levels. While aromatase inhibitors reduce breast cancer incidence, their influence on endometrial cancer is uncertain. METHODS: We addressed this issue in a cohort of 17,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Chlebowski, Rowan T., Schottinger, Joanne E., Shi, Jiaxiao, Chung, Joanie, Haque, Reina
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565775/
https://ncbi.nlm.nih.gov/pubmed/25757699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29332
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!